Today: 20 May 2026
Browse Category

NASDAQ:CGON 11 January 2026 - 12 January 2026

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology shares surged 29.3% to $54.20 after the company moved up its Phase 3 PIVOT-006 trial timeline, now expecting topline results in early 2026. Trading volume reached 7 million shares. Analysts raised price targets following the update and ahead of the JPMorgan Healthcare Conference. The trial enrolls over 360 bladder cancer patients and measures recurrence-free survival.
12 January 2026
··
CG Oncology stock (CGON) jumps 29% on faster PIVOT-006 Phase 3 readout — what to watch next

CG Oncology stock (CGON) jumps 29% on faster PIVOT-006 Phase 3 readout — what to watch next

CG Oncology shares surged 29% Friday to $54.20 after the company moved up its Phase 3 PIVOT-006 data release to early 2026. Morgan Stanley raised its price target to $93 and increased the program’s success probability to 70%. The company cited faster enrollment and no severe adverse events in recent data. CG Oncology will present at the J.P. Morgan Healthcare Conference on January 15.
11 January 2026
·
CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology shares jumped nearly 29% Friday, closing at $54.20, after the company said topline Phase 3 trial data for its bladder cancer therapy will arrive in the first half of 2026, almost a year early. Morgan Stanley raised its price target to $93, citing the accelerated timeline. The PIVOT-006 trial enrolled over 360 patients at more than 90 sites.
11 January 2026
··

Stock Market Today

  • US Stocks Rally as Bond Market Pressure Eases and Oil Prices Decline
    May 20, 2026, 4:45 PM EDT. U.S. stocks rallied Wednesday, with the S&P 500 rising 1.1% after relief in the bond market reduced market pressure. Falling oil prices also helped ease concerns, contributing to the positive momentum. This rebound follows a period of volatility influenced by rising bond yields and surging crude prices, which typically raise borrowing costs and impact energy sectors. Investors remain cautious but encouraged by the easing dynamics in fixed income and commodities.

Latest articles

RBC Stock Tops 52-Week High Ahead of May 28

RBC Stock Tops 52-Week High Ahead of May 28

20 May 2026
Royal Bank of Canada shares hit a 52-week high of C$257.91 on Wednesday, closing up 1.99% at C$257.55. Fitch upgraded RBC’s legacy senior long-term debt rating to AA+ from AA on May 19. Investors await RBC’s second-quarter results, set for May 28. The S&P/TSX Composite Index rose 0.9% as most sectors advanced.
Arm Jumps 15% as AI CPU Trade Picks Up

Arm Jumps 15% as AI CPU Trade Picks Up

20 May 2026
Arm’s U.S.-listed ADRs jumped 15.1% to $256.73 on Wednesday after Bernstein initiated coverage with an outperform rating and $300 target. The rally came ahead of Nvidia’s results and amid a broader chip stock surge. Arm reported record quarterly revenue and strong demand for its new AGI CPU. Ongoing U.S. antitrust scrutiny and supply constraints remain concerns.
Reddit Pushes Past $150 but Ad Campaign Still Lags

Reddit Pushes Past $150 but Ad Campaign Still Lags

20 May 2026
Reddit shares fell 5.2% to $146.84 late Wednesday, underperforming broader tech indexes despite launching new app-advertising tools. A trust linked to CEO Steve Huffman sold 18,000 shares last week, according to an SEC filing. Reddit reported Q1 revenue of $663 million, up 69% year over year, and set Q2 revenue guidance between $715 million and $725 million.
Go toTop